Harley Oliver
Medical · Mobile, ALNPI 1134617996
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 269 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 45.9% of the total. Reporting peaked in 2021 at $926 and has fallen 64.2% since, to $331 in 2025.
Across 269 payments — averaging $13.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Collegium Pharmaceutical, Inc.$356
- Valinor Pharma, LLC$354
- Arbor Pharmaceuticals, Inc.$220
- Amgen$182
- Almatica Pharma LLC$122
- plus $683 from 14 others
What the payments were for
- Food & beverage$3,541100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 155 | $1,624 |
| Collegium Pharmaceutical, Inc. | 19 | $356 |
| Valinor Pharma, LLC | 24 | $354 |
| Arbor Pharmaceuticals, Inc. | 14 | $220 |
| Amgen | 13 | $182 |
| Almatica Pharma LLC | 6 | $122 |
| Biodelivery Sciences International, Inc. | 7 | $117 |
| Medtronic | 6 | $101 |
| Hikma Pharmaceuticals USA | 4 | $59 |
| Scilex Pharmaceuticals Inc. | 3 | $56 |
| Forte Bio-pharma LLC | 2 | $49 |
| Vertex | 2 | $48 |
| Virtus Pharmaceuticals LLC | 2 | $48 |
| Azurity Pharmaceuticals, Inc. | 3 | $47 |
| Redhill Biopharma Inc. | 3 | $46 |
| Boston Scientific | 2 | $33 |
| Tonix Medicines, Inc. | 1 | $23 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| IBSA Pharma Inc. | 1 | $15 |
How this compares
$3,541 in reported general payments places this provider in the 80th percentile of 175 medical providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 75 | $47,220 |
| RelistorMethylnaltrexone Bromide | 11 | $26,877 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 545 | $13,205 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 261 | $11,869 |
| Buprenorphine | 63 | $11,054 |
| LinzessLinaclotide | 16 | $10,491 |
| Gabapentin | 250 | $3,281 |
| Diclofenac Sodium | 67 | $2,752 |
| Lidocaine | 24 | $1,916 |
| Tizanidine Hcl | 115 | $1,716 |
| Pregabalin | 71 | $1,402 |
| Duloxetine Hcl | 34 | $958 |
| Oxycodone Hcl | 65 | $775 |
| Cyclobenzaprine Hcl | 64 | $725 |
| Celecoxib | 32 | $720 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $356 | $47,22075 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,624 | $26,87711 claims |
| Hikma Pharmaceuticals USABuprenorphine | $59 | $11,05463 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 175 medical providers in Alabama.
Other medical in Mobile
- Stacy RichersonMobile$12K
- Noel ZvonarMobile$5K
- Hannah DunnMobile$4K
- Jimmie BlanMobile$4K
- Stephanie AikinMobile$2K
- Courtney RiggsMobile$2K
- Lindsey MangumFlorence$44K
- Jaime DunnBirmingham$16K
- Susannah CashAuburn$11K
- Deana PorterAuburn$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.